| sex chromatin |
| histone H2A-K119 monoubiquitination |
| PRC1 complex |
| histone H2A monoubiquitination |
| histone H2A ubiquitination |
| PcG protein complex |
| histone monoubiquitination |
| negative regulation of G0 to G1 transition |
| histone ubiquitination |
| regulation of G0 to G1 transition |
| promoter-specific chromatin binding |
| chromatin organization involved in negative regulation of transcription |
| chromatin silencing |
| protein monoubiquitination |
| chromatin organization involved in regulation of transcription |
| cellular response to hydrogen peroxide |
| negative regulation of gene expression, epigenetic |
| embryonic skeletal system morphogenesis |
| histone acetylation |
| cellular response to antibiotic |
| response to hydrogen peroxide |
| internal peptidyl-lysine acetylation |
| peptidyl-lysine acetylation |
| internal protein amino acid acetylation |
| embryonic skeletal system development |
| cellular response to reactive oxygen species |
| protein acetylation |
| gene silencing |
| protein acylation |
| response to reactive oxygen species |
| cellular response to toxic substance |
| anterior/posterior pattern specification |
| negative regulation of apoptotic signaling pathway |
| regulation of gene expression, epigenetic |
| nuclear chromatin |
| skeletal system morphogenesis |
| cellular response to oxidative stress |
| nuclear body |
| embryonic organ morphogenesis |
| response to antibiotic |
| peptidyl-lysine modification |
| negative regulation of cell cycle process |
| regionalization |
| histone modification |
| covalent chromatin modification |
| in utero embryonic development |
| response to oxidative stress |
| regulation of apoptotic signaling pathway |
| cellular response to drug |
| embryonic organ development |
| pattern specification process |
| skeletal system development |
| response to toxic substance |
| response to inorganic substance |
| embryonic morphogenesis |
| negative regulation of cell cycle |
| chordate embryonic development |
| embryo development ending in birth or egg hatching |
| DNA-binding transcription factor activity |
| protein ubiquitination |
| chromatin organization |
| regulation of cell cycle process |
| protein modification by small protein conjugation |
| negative regulation of transcription by RNA polymerase II |
| peptidyl-amino acid modification |
| negative regulation of apoptotic process |
| negative regulation of programmed cell death |
| animal organ morphogenesis |
| embryo development |
| protein modification by small protein conjugation or removal |
| negative regulation of cell death |
| response to drug |
| cellular response to oxygen-containing compound |
| chromosome organization |
| regulation of cell cycle |
| negative regulation of transcription, DNA-templated |
| negative regulation of nucleic acid-templated transcription |
| negative regulation of RNA biosynthetic process |
| negative regulation of signal transduction |
| negative regulation of RNA metabolic process |
| negative regulation of cell communication |
| negative regulation of signaling |
| negative regulation of cellular macromolecule biosynthetic process |
| negative regulation of nucleobase-containing compound metabolic process |
| DNA binding |
| negative regulation of macromolecule biosynthetic process |
| negative regulation of cellular biosynthetic process |
| regulation of apoptotic process |
| negative regulation of biosynthetic process |
| response to oxygen-containing compound |
| regulation of programmed cell death |
| negative regulation of response to stimulus |
| regulation of cell death |
| cellular response to stress |
| negative regulation of gene expression |